{
    "clinical_study": {
        "@rank": "36973", 
        "arm_group": [
            {
                "arm_group_label": "ICSI group", 
                "arm_group_type": "Active Comparator", 
                "description": "In this group, sperm selected for injection will be morphologically evaluated under 400x magnification"
            }, 
            {
                "arm_group_label": "IMSI group", 
                "arm_group_type": "Experimental", 
                "description": "In this group, sperm selected for injection will be morphologically evaluated under 6600x magnification"
            }
        ], 
        "brief_summary": {
            "textblock": "There is a lack of clarity regarding the justification to instruct the couple to shift from\n      intracytoplasmic sperm injection (ICSI) to intracytoplasmic morphologically selected sperm\n      injection (IMSI). In this study, we aim at evaluating the efficacy of IMSI in couples with\n      previous implantation failure with ICSI."
        }, 
        "brief_title": "IMSI in Couples With Previous Implantation Failures", 
        "condition": [
            "Male Infertility", 
            "Female Infertility"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Infertility, Female", 
                "Infertility, Male"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with ICSI indication, who have previously underwent >= 1 ICSI attempt in\n             which at least 2 blastocysts were transferred, with no implantation.\n\n          -  Regular menstrual cycles every 25-35 days.\n\n          -  Body Mass Index less than 35 as calculated according to the following formula: body\n             weight (kg) / height x height (m2)\n\n          -  Presence of both ovaries.\n\n          -  No pelvic and / or clinically significant uterine anomalies.\n\n          -  Normal cervical cytology.\n\n          -  Serum follicle stimulating hormone (FSH) within normal limits.\n\n        Exclusion Criteria:\n\n          -  Clinically significant systemic disease.\n\n          -  Infection by the human immunodeficiency virus (HIV).\n\n          -  Infection by the by the hepatitis C virus\n\n          -  Positive test for surface antigens of hepatitis B.\n\n          -  Endometriosis stages III - IV (classification of the American Society for\n             Reproductive Medicine).\n\n          -  Hydrosalpinx, unilateral or bilateral.\n\n          -  Abnormal gynecological bleeding, undiagnosed.\n\n          -  Allergy or hypersensitivity to human gonadotropin preparations or any other related\n             to the study medication.\n\n        -Simultaneous participation in another clinical trial.  -"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "386", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02107521", 
            "org_study_id": "Sapi IMSI IF"
        }, 
        "intervention": [
            {
                "arm_group_label": "IMSI group", 
                "description": "Sperm selection for injection will be performed at 6600x magnification", 
                "intervention_name": "Intracytoplasmic morphologically selected sperm injection", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "ICSI group", 
                "description": "sperm selection for injection will be performed under 400x magnification", 
                "intervention_name": "Intracytoplasmic sperm injection", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "sperm morphology", 
            "ICSI", 
            "IMSI", 
            "implantation", 
            "pregnancy"
        ], 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "contact": {
                "email": "science@sapientiae.org.br", 
                "last_name": "Edson Borges, PhD", 
                "phone": "55113018818"
            }, 
            "facility": {
                "address": {
                    "city": "Sao Paulo", 
                    "country": "Brazil", 
                    "zip": "04503-040"
                }, 
                "name": "Fertility - Centro de Fertiliza\u00e7\u00e3o Assistida"
            }, 
            "investigator": {
                "last_name": "Amanda S Raize, B.Sc.", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of the Intracytoplasmic Morphologically Selected Sperm Injection in Couples With Previous Implantation Failure After Intracytoplasmic Sperm Injection", 
        "overall_contact": {
            "email": "science@fertility.com.br", 
            "last_name": "Edson Borges Jr., PhD", 
            "phone": "551130188181"
        }, 
        "overall_official": {
            "affiliation": "Sapientiae Institute", 
            "last_name": "Edson Borges, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The presence of a gestational sac with heart beat, visualized upon ultrasound scan at 4-5 weeks' gestation", 
            "measure": "Implantation", 
            "safety_issue": "No", 
            "time_frame": "4-5 weeks' gestation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02107521"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Sapientiae Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sapientiae Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}